A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
Abroad (travel likely)RecruitingPHASE1
Conditions
Type 2 Diabetes Mellitus (T2DM) · Non-Alcoholic Fatty Liver Disease (NAFLD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centricity Research Toronto LMC., Toronto, Canada
Contact: Study coordinator (Clinical Research Coordinator) · arlene.vinas@centricityresearch.com · 416-645-2929, Ext 9232
Study leads
Andrew Keates, PhD
Study Director
1Globe Health Institute